Literature DB >> 23026936

Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas.

Werner Kempf1, Dmitry V Kazakov, Leo Schärer, Arno Rütten, Thomas Mentzel, Bruno E Paredes, Gabriele Palmedo, Renato G Panizzon, Heinz Kutzner.   

Abstract

Lymphomatoid papulosis (LyP) belongs to the spectrum of primary cutaneous CD30-positive lymphoproliferative disorders. Clinically, LyP is characterized by a variable number of self-healing papulo-nodular lesions, with the typical waxing and waning course. Histologically, 4 types (A, B, C, and D) have been delineated. Angioinvasive growth and large ulcers are rare findings in LyP and simulate aggressive lymphoma. We retrospectively analyzed the clinicopathologic and molecular features of angioinvasive LyP in a series of 16 patients. This new form of LyP is characterized by oligolesional papules that rapidly ulcerate and evolve into large necrotic eschar-like lesions with a diameter of 1 to 4 cm and an angiocentric and angiodestructive infiltrate of small-sized to medium-sized atypical lymphocytes expressing CD30 and frequently CD8. As in other forms of LyP, the lesions underwent spontaneous regression after a few weeks. Recurrences were common, but the prognosis was excellent with no extracutaneous spread or disease-related deaths. Complete remission occurred in 9 of 16 patients (56%). This LyP variant should be distinguished from aggressive forms of angiocentric and angiodestructive and cytotoxic T-cell lymphomas. We propose the term LyP type E for this clinically and histologically unusual variant.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23026936     DOI: 10.1097/PAS.0b013e3182648596

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  16 in total

1.  Defining the elusive boundaries of chronic active Epstein-Barr virus infection.

Authors:  Sebastian Fernandez-Pol; Oscar Silva; Yasodha Natkunam
Journal:  Haematologica       Date:  2018-06       Impact factor: 9.941

Review 2.  [Cutaneous lymphomas: new entities and rare variants].

Authors:  W Kempf; C Mitteldorf
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

Review 3.  [WHO classification and clinical spectrum of cutaneous lymphomas].

Authors:  C Mitteldorf; S Grabbe; R Stadler
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

4.  C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment.

Authors:  Shamir Geller; Travis J Hollmann; Steven M Horwitz; Patricia L Myskowski; Melissa Pulitzer
Journal:  Histopathology       Date:  2019-11-13       Impact factor: 5.087

Review 5.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

Review 6.  The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.

Authors:  Rein Willemze; Lorenzo Cerroni; Werner Kempf; Emilio Berti; Fabio Facchetti; Steven H Swerdlow; Elaine S Jaffe
Journal:  Blood       Date:  2019-01-11       Impact factor: 22.113

Review 7.  Recent advances in cutaneous lymphoma-implications for current and future classifications.

Authors:  J R Goodlad; L Cerroni; S H Swerdlow
Journal:  Virchows Arch       Date:  2022-10-24       Impact factor: 4.535

8.  Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid Papulosis.

Authors:  Nadège Cordel; Benoît Tressières; Michel D'Incan; Laurent Machet; Florent Grange; Éric Estève; Sophie Dalac; Saskia Ingen-Housz-Oro; Martine Bagot; Marie Beylot-Barry; Pascal Joly
Journal:  Oncologist       Date:  2015-12-14

9.  A Severe Case of Lymphomatoid Papulosis Type E Successfully Treated with Interferon-Alfa 2a.

Authors:  Aslı Bilgiç Temel; Betül Unal; Hatice Erdi Şanlı; Şeniz Duygulu; Soner Uzun
Journal:  Case Rep Dermatol Med       Date:  2017-04-30

10.  Single-Fraction Radiotherapy for CD30(+) Lymphoproliferative Disorders.

Authors:  Michelle S Gentile; Maria Estela Martinez-Escala; Tarita O Thomas; Joan Guitart; Steven Rosen; Timothy Kuzel; Bharat B Mittal
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.